Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaboration; Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, Colhoun H, Braunwald E, La Rosa J, Pedersen TR, Tonkin A, Davis B, Sleight P, Franzosi MG, Baigent C, Keech A. Cholesterol Treatment Trialists' (CTT) Collaboration, et al. Among authors: kirby a. Lancet. 2015 Apr 11;385(9976):1397-405. doi: 10.1016/S0140-6736(14)61368-4. Epub 2015 Jan 9. Lancet. 2015. PMID: 25579834 Free article.
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk; Cholesterol Treatment Trialists’ (CTT) Collaboration. Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk, et al. Lancet Diabetes Endocrinol. 2024 May;12(5):306-319. doi: 10.1016/S2213-8587(24)00040-8. Epub 2024 Mar 27. Lancet Diabetes Endocrinol. 2024. PMID: 38554713 Free PMC article.
Understanding national Societies' needs and enhancing collaboration with ESTRO: A report of the national Societies survey 2024, on behalf of the ESTRO national Societies committee.
Atalar B, Mastroleo F, Zaffaroni M, Cremades V, Doolan P, Rønde HS, Clark CH, van der Heide UA, Boldrini L, Eriksen JG, Forde E, Kirby AM, Guckenberger M, Garibaldi C, Jereczek-Fossa BA. Atalar B, et al. Among authors: kirby am. Radiother Oncol. 2025 Jun 28:111006. doi: 10.1016/j.radonc.2025.111006. Online ahead of print. Radiother Oncol. 2025. PMID: 40588037
Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial.
Kirby AM, Finneran L, Griffin CL, Brunt AM, Cafferty FH, Alhasso A, Chan C, Haviland JS, Jefford ML, Sawyer EJ, Sydenham MA, Syndikus I, Tsang YM, Wheatley D, Yarnold JR, Coles CE, Bliss JM. Kirby AM, et al. Lancet Oncol. 2025 Jun 11:S1470-2045(25)00194-9. doi: 10.1016/S1470-2045(25)00194-9. Online ahead of print. Lancet Oncol. 2025. PMID: 40516558 Free article.
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study.
Brunt AM, Cafferty FH, Wheatley D, Sydenham MA, Kirby AM, Coles CE, Patel J, Alhasso A, Chan C, Cleator S, Fleming H, Gahir D, Goodman A, Griffin C, Haviland JS, Kirwan C, Nabi Z, Poole K, Sawyer E, Sinclair J, Somaiah N, Syndikus I, Venables K, Yarnold J, Bliss JM. Brunt AM, et al. Among authors: kirby am. Radiother Oncol. 2025 Jun;207:110915. doi: 10.1016/j.radonc.2025.110915. Epub 2025 May 4. Radiother Oncol. 2025. PMID: 40379410 Free article. Clinical Trial.
1,104 results